|
|
Article: Murex Clinical Technologies broadens product range and manufacturing base through acquisition of Dominion Biologicals Limited.
- Article from:
- PR Newswire
- Article date:
- January 11, 1990
CopyrightCOPYRIGHT 1990 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MUREX CLINICAL TECHNOLOGIES BROADENS PRODUCT RANGE AND MANUFACTURING
BASE THROUGH ACQUISITION OF DOMINION BIOLOGICALS LIMITED
VANCOUVER, British Columbia, Jan. 11 /PRNewswire/ --- Murex Clinical Technologies Corporation (symbol V.MCI), a Canadian healthcare systems company, today announced the acquisition of Dominion Biologicals Limited of Dartmouth, Nova Scotia.
Murex Clinical views the acquisition of Dominion as an important strategic fit which will further the Corporation's objective to establish a complete line of diagnostic products and test systems for all markets, from blood screening at large clinics to individual tests done in ...